Abstract
A novel series of 2,6-diphenoxypyridines has been designed to inhibit factor Xa, a serine protease strategically located in the coagulation cascade. The evolution from the photochemically unstable bisamidine (Z,Z)-BABCH to potent bisamidine compounds with a pyridine heterocycle as the core scaffold has been achieved. The most potent compound in the series, 6h, has a Ki for human factor Xa of 12 nM. The selectivity of 6h against bovine trypsin and human thrombin was greater than 90- and 1000-fold, respectively. Two proposed modes of binding of 6h to factor Xa are made based on the crystal structures of 6h by itself and of 6h bound to bovine trypsin.
MeSH terms
-
Amidines / chemical synthesis*
-
Amidines / chemistry
-
Animals
-
Cattle
-
Crystallography, X-Ray
-
Drug Design
-
Factor Xa Inhibitors*
-
Fibrinolytic Agents / chemical synthesis*
-
Fibrinolytic Agents / chemistry
-
Humans
-
Models, Molecular
-
Molecular Conformation
-
Pyridines / chemical synthesis*
-
Pyridines / chemistry
-
Stereoisomerism
-
Structure-Activity Relationship
-
Thrombin / antagonists & inhibitors
-
Trypsin Inhibitors / chemical synthesis
-
Trypsin Inhibitors / chemistry
Substances
-
3,3'-(3,5-difluoro-4-methyl-2,6-pyridinediylbis(oxy))bis(benzenecarbox(imide)amide)
-
Amidines
-
Factor Xa Inhibitors
-
Fibrinolytic Agents
-
Pyridines
-
Trypsin Inhibitors
-
Thrombin